We care about your data, and we'd use cookies only to improve your experience. By using this website, you accept our Cookies Policy.
PharmStars Digital Health Accelerator White Logo

Accelerating successful digital health startup-pharma partnerships

Applications now being accepted for
PharmStars’ Fall 2026 cohort
Digital Innovations in Immunology

Watch this space!

Apply Now!

About PharmStarsTM

PharmStars is the pharma-focused accelerator for digital health startups, dedicated to driving digital health adoption to improve patient outcomes. We educate and mentor digital health startups seeking engagement with pharma and biotech firms. We are supported by our pharma members who are committed to working with startups that graduate from our accelerator.

PharmStars’ mission is to facilitate and accelerate successful partnerships between digital health startups and pharma, leading to greater success for each and faster adoption of digital health to improve patient outcomes.

10

Cohorts

completed

112

Startups

graduated

99%

Graduation

rate

$1B+

Cumulative
funding

raised by alumni

100+

Pharma Deals

Among first 35 graduates

Promise of digital health

Digital health has the potential to transform the pharmaceutical industry and the patient experience. Digital health and pharma firms are eager to engage with one another. Yet both have found it challenging to create successful partnerships.

Bridging the pharma-startup gap

Digital health has the potential to transform the pharmaceutical industry and the patient experience. Pharma firms and innovative digital health startups are eager to collaborate to achieve these wins. Yet both have found it challenging to create successful partnerships.

PharmStars is the only digital health accelerator aimed at bridging the pharma-startup gap to drive greater adoption of digital health. Our 10-week accelerator is designed to prepare startups for more productive engagements with pharma, teaching them how drugs are developed, how pharma is organized, and about the biopharma industry. The program culminates with the Startup Showcase. Startups present their solutions to our pharma members and then have the opportunity to meet individually with them.

"Our mission is to facilitate and accelerate successful partnerships between digital health startups and pharma, leading to greater success for each and faster adoption of digital health to improve patient outcomes."
- Naomi Fried PhD, Founder & CEO, PharmStars

Accelerator Highlights

Our next cohort is about to launch! Digital health startups, with market-ready solutions in our theme area and interested in engaging with pharma, are encouraged to apply. Please refer to our Accelerator Terms for the detailed requirements.

Our next cohort is about to launch! Digital health startups, with market-ready solutions in our theme area and interested in engaging with pharma, are encouraged to apply. Please refer to our Program Terms for the detailed requirements.

Our next cohort is about to launch! Digital health startups with market-ready solutions in our theme area and interested in engaging with pharma, are encouraged to apply. Please refer to our Accelerator Terms for the detailed requirements.

Icon - Target

Cohort Theme: Digital Innovations in Immunology

Icon - person presenting in front of. screen in front of people

Pharma Curriculum

Personalized
Mentoring

Icon - presenter at podium

Pitch Presentation
to Pharma

Startup
Funding

Graduate School

Fall 2026 Cohort Theme:
-
Digital Innovations in Immunology

Immunology is the study of the body’s immune system, which is highly complex and interconnected with nearly every organ system. When the immune system malfunctions, it can lead to a broad range of disorders, including autoimmune diseases, inflammatory conditions, allergies, and asthma. These conditions affect hundreds of millions of people worldwide (1). Because many of these conditions are lifelong and often characterized by unpredictable, periodic flares, they require intensive, long-term management and significant patient engagement.

Advances in the scientific understanding of the immune system have enabled novel, powerful pharmacological interventions for both classical immune-based diseases and other conditions. Today, patients benefit from immunological therapies, including vaccines to prevent infectious diseases, immuno-oncology treatments to fight cancer, and advanced cellular immunotherapies.

The highly individualized and dynamic nature of immune responses can make diagnosis, treatment, disease monitoring, and prediction of response to therapeutic intervention difficult. Furthermore, the complexity of the immune system and the broad range of immunological conditions create unique challenges for the pharmaceutical industry across drug discovery, clinical development, and patient care.

Digital innovations have the unique potential to support and transform pharma’s multifaceted activities in immunology.The theme of the PharmStars’ Fall 2026 cohort is “Digital Innovations in Immunology.” Applications are welcome from startups with digital innovations in immunological disease prevention, diagnosis, treatment, and patient care. Areas of interest include, but are not limited to:

    1. 1. Immunological Disease Identification, Monitoring, and Personalization
    • Improving patient identification and diagnosis
    • Enabling personalized treatment and predicting individual responses
    • Monitoring immune activity and disease progression
    • Predicting and monitoring disease flares
    • Collecting real-world data
    1. 2. Novel Development of New Immunological Therapies
      • Developing novel digital biomarkers
      • Enabling faster, better identification of drug or vaccine targets
      • Supporting vaccine, immuno-oncology, and advanced cellular immunotherapy distribution, delivery, and response monitoring
    1. 3. Enhancing Immunology Drug Development and Safety
        • Improving clinical trials design or operations
        • Leveraging remote monitoring and wearables
        • Identifying patients at risk for and/or monitoring of immune-related adverse events (irAEs)
    1. 4. Improving Patient Care and Outcomes
        • Advancing patient access and improving health equity
        • Providing patient, family, and provider education and care coordination
        • Improving treatment adherence
        • Navigating long-term, chronic immune disease care and engagement

Digital health startups with a product or prototype addressing any aspect of the theme are invited to apply by July 12, 2026. For more details and program requirements, please refer to the Accelerator Terms.

1. https://www.jaadinternational.org/article/S2666-3287(24)00180-9/fulltext

    Digital health startups that have an innovative clinical trial product or prototype are encouraged to apply.  The application deadline is July 15, 2024. For details and program requirements, please refer to the Program Terms.

    Oncology drug discovery tools
    • Target identification and selection
    • Drug candidate selection
    Oncology drug delivery platforms
    Clinical trials tools
    • Participant recruitment and retention
    • Trial design and execution
    • Personalized treatment and health equity
    Provider tools for:
    • Information management and therapy selection
    • Cancer detection and diagnosis
    • Remote patient monitoring
    Patient care solutions for:
    • Side effect management
    • Medication adherence
    • Communication, navigation, and education
    • Caregiver support
      • RWE analysis
      • Therapy adherence
      • Self-care management
      • Care-giver solutions

      Fall 2026 Timeline

      Applications open

      June 1

      Icon - arrow pointing right

      Applications due

      July 12

      Icon - arrow pointing right

      Acceptances sent

      August 26

      Icon - arrow pointing right

      Launch Event

      September 9-10

      Icon - arrow pointing right

      Virtual PharmaU

      September 14 - November 5

      Icon - arrow pointing right

      Startup Showcase

      Mid-November 2026

      PharmaUTM

      The centerpiece of the PharmStars accelerator is PharmaU: a unique, comprehensive educational program. Its three components are a curriculum for startups, mentoring for startups, and "Executive Ed" programming for pharma leadership. PharmaU’s courses are developed and led by PharmStars’ experienced team of former pharma executives with deep expertise in digital health, innovation, and startups.

      Picture - pile of books

      Curriculum

      Courses for startups about how to engage pharma successfully include topics such as:

      • drug development process
      • pharma’s internal structures and functions
      • pharma business models
      • regulatory drivers
      • pharma-startup deal structures
      Picture - person crossing a bridge whilst its being built in front of them

      Mentoring

      Individualized coaching from our PharmStars staff on how startups can successfully engage pharma. We guide startups on applying their PharmaU education, from building a compelling value proposition through crafting an effective pharma-oriented pitch.

      Executive Education

      Workshops and seminars for pharma members, providing insight and peer-to-peer discussions on digital health innovation and startup partnerships.

      Are You Ready?

      PharmStars is Accepting Applications for Our Fall 2026 Cohort Until July 12!